Login / Signup
Zhan-Cheng Qiu
(Zhancheng Qiu)
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 7
Top Topics
Ejection Fraction
Prognostic Factors
Chronic Kidney Disease
Top Venues
Cancer medicine
Annals of surgical treatment and research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Zhan-Cheng Qiu
,
You-Wei Wu
,
Wei-Li Qi
,
Lun-Xu Liu
Safety of nighttime elective hepatectomy for hepatocellular carcinoma patients: a retrospective study.
Annals of surgical treatment and research
106 (2) (2024)
Zhan-Cheng Qiu
,
You-Wei Wu
,
Wei-Li Qi
,
Lun-Xu Liu
Safety of nighttime elective hepatectomy for hepatocellular carcinoma patients: a retrospective study.
Annals of surgical treatment and research
106 (2) (2024)
Zhan-Cheng Qiu
,
You-Wei Wu
,
Wei-Li Qi
,
Chuan Li
PIVKA-II combined with tumor burden score to predict long-term outcomes of AFP-negative hepatocellular carcinoma patients after liver resection.
Cancer medicine
13 (1) (2023)
Zhan-Cheng Qiu
,
You-Wei Wu
,
Wei-Li Qi
,
Chuan Li
PIVKA-II combined with tumor burden score to predict long-term outcomes of AFP-negative hepatocellular carcinoma patients after liver resection.
Cancer medicine
(2023)
Zhan-Cheng Qiu
,
Wei-Li Qi
,
Youwei Wu
,
Lingling Li
,
Chuan Li
Insurance status impacts survival of hepatocellular carcinoma patients after liver resection.
Cancer medicine
(2023)
Zhan-Cheng Qiu
,
You-Wei Wu
,
Wei-Li Qi
,
Chuan Li
PIVKA-II combined with tumor burden score to predict long-term outcomes of AFP-negative hepatocellular carcinoma patients after liver resection.
Cancer medicine
(2023)
Zhan-Cheng Qiu
,
You-Wei Wu
,
Wei-Li Qi
,
Chuan Li
PIVKA-II combined with tumor burden score to predict long-term outcomes of AFP-negative hepatocellular carcinoma patients after liver resection.
Cancer medicine
(2023)